Revolutionary Tech Transforms Pharmaceutical Freeze-Drying!

BIOT

featured image of Revolutionary Tech Transforms Pharmaceutical Freeze-Drying!
🔍 A new technology for monitoring freeze-drying in pharmaceuticals is here! Developed by De Montfort University, LyoVIS® uses through-vial impedance spectroscopy.

💡 This innovative method enhances the stability of injectable drugs by analyzing their properties during freeze-drying. It addresses scale-up challenges, filling a gap in the market for contract developers.

⚙️ Early installations are planned for potential customers to test this groundbreaking instrument.

📢 Revolutionary Tech Transforms Freeze-Drying for Pharmaceuticals!

Introduction:

The article discusses the innovative application of through-vial impedance spectroscopy (TVIS) in monitoring the freeze-drying process of injectable drug products. Led by researchers from De Montfort University, this technological advancement aims to enhance the stability and shelf life of biological products that often require freeze-drying for storage and distribution.

Main points:

  1. TVIS is introduced as a new process analytical technology that allows real-time monitoring of formulations during the freeze-drying cycle.
  2. Dr. Geoff Smith emphasizes the growing significance of this technique in the pharmaceutical industry, particularly for de-risking the scale-up of freeze-dried injectable drugs.
  3. The LyoVIS® technology is described as a first-in-class device that utilizes electrical impedance spectroscopy to measure the dielectric relaxation of ice, filling a gap in current monitoring methods.
  4. The authors highlight that traditional off-line tools have limitations in assessing the formulation’s behavior, which this new technology aims to overcome.
  5. Future plans include trial installations of the LyoVIS system at customer sites to further evaluate its efficacy in real-world applications.

Conclusion:

The introduction of TVIS via LyoVIS represents a significant advancement in the freeze-drying process monitoring of injectable drugs, addressing current technological gaps and enhancing process reliability. As pharmaceutical companies seek more robust manufacturing processes, the application of this innovative monitoring technique may streamline production and contribute to improved patient safety with more stable biological products. Future installations and evaluations will be critical in determining the widespread adaptability of this technology in the industry.

Leave a Comment